JP2020164483A - Oral gel-like composition - Google Patents
Oral gel-like composition Download PDFInfo
- Publication number
- JP2020164483A JP2020164483A JP2019068455A JP2019068455A JP2020164483A JP 2020164483 A JP2020164483 A JP 2020164483A JP 2019068455 A JP2019068455 A JP 2019068455A JP 2019068455 A JP2019068455 A JP 2019068455A JP 2020164483 A JP2020164483 A JP 2020164483A
- Authority
- JP
- Japan
- Prior art keywords
- composition
- gel
- vitamin
- oral gel
- gellan gum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 123
- 229920002148 Gellan gum Polymers 0.000 claims abstract description 44
- 239000000216 gellan gum Substances 0.000 claims abstract description 40
- 235000010492 gellan gum Nutrition 0.000 claims abstract description 39
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims description 53
- 229940041672 oral gel Drugs 0.000 claims description 32
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 7
- 239000003814 drug Substances 0.000 claims description 7
- 235000019157 thiamine Nutrition 0.000 claims description 7
- 239000011721 thiamine Substances 0.000 claims description 7
- 229940079593 drug Drugs 0.000 claims description 6
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 5
- 229940127557 pharmaceutical product Drugs 0.000 claims description 5
- 229960003495 thiamine Drugs 0.000 claims description 5
- UDCIYVVYDCXLSX-SDNWHVSQSA-N n-[(4-amino-2-methylpyrimidin-5-yl)methyl]-n-[(e)-5-hydroxy-3-(propyldisulfanyl)pent-2-en-2-yl]formamide Chemical compound CCCSS\C(CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N UDCIYVVYDCXLSX-SDNWHVSQSA-N 0.000 claims description 4
- GFEGEDUIIYDMOX-BMJUYKDLSA-N n-[(4-amino-2-methylpyrimidin-5-yl)methyl]-n-[(z)-3-[[(z)-2-[(4-amino-2-methylpyrimidin-5-yl)methyl-formylamino]-5-hydroxypent-2-en-3-yl]disulfanyl]-5-hydroxypent-2-en-2-yl]formamide Chemical compound C=1N=C(C)N=C(N)C=1CN(C=O)C(\C)=C(CCO)/SSC(/CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N GFEGEDUIIYDMOX-BMJUYKDLSA-N 0.000 claims description 4
- 229950007142 prosultiamine Drugs 0.000 claims description 4
- 229960001385 thiamine disulfide Drugs 0.000 claims description 4
- 229910002651 NO3 Inorganic materials 0.000 claims description 3
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims description 3
- BTNNPSLJPBRMLZ-LGMDPLHJSA-N benfotiamine Chemical compound C=1C=CC=CC=1C(=O)SC(/CCOP(O)(O)=O)=C(/C)N(C=O)CC1=CN=C(C)N=C1N BTNNPSLJPBRMLZ-LGMDPLHJSA-N 0.000 claims description 3
- 229960002873 benfotiamine Drugs 0.000 claims description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 3
- 229960000344 thiamine hydrochloride Drugs 0.000 claims description 3
- 235000019190 thiamine hydrochloride Nutrition 0.000 claims description 3
- 239000011747 thiamine hydrochloride Substances 0.000 claims description 3
- UIERGBJEBXXIGO-UHFFFAOYSA-N thiamine mononitrate Chemical compound [O-][N+]([O-])=O.CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N UIERGBJEBXXIGO-UHFFFAOYSA-N 0.000 claims description 3
- AZJUFRDUYTYIHV-NKFKGCMQSA-N Dibenzoyl Thiamine Chemical compound C=1C=CC=CC=1C(=O)OCC\C(SC(=O)C=1C=CC=CC=1)=C(/C)N(C=O)CC1=CN=C(C)N=C1N AZJUFRDUYTYIHV-NKFKGCMQSA-N 0.000 claims 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 1
- 229950006791 bentiamine Drugs 0.000 claims 1
- 239000011691 vitamin B1 Substances 0.000 abstract 3
- 235000010374 vitamin B1 Nutrition 0.000 abstract 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 34
- -1 thiamine dicetyl sulfate ester salts Chemical class 0.000 description 26
- 238000000926 separation method Methods 0.000 description 24
- 235000013305 food Nutrition 0.000 description 17
- JTLXCMOFVBXEKD-FOWTUZBSSA-N fursultiamine Chemical compound C1CCOC1CSSC(\CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N JTLXCMOFVBXEKD-FOWTUZBSSA-N 0.000 description 17
- 239000007788 liquid Substances 0.000 description 16
- 238000003860 storage Methods 0.000 description 14
- 239000000796 flavoring agent Substances 0.000 description 12
- 239000000499 gel Substances 0.000 description 12
- 238000000034 method Methods 0.000 description 12
- 229950006836 fursultiamine Drugs 0.000 description 11
- 239000000463 material Substances 0.000 description 11
- 238000002360 preparation method Methods 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 150000003839 salts Chemical class 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 238000009472 formulation Methods 0.000 description 9
- 235000019634 flavors Nutrition 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 7
- 238000004806 packaging method and process Methods 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 229930003231 vitamin Natural products 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 239000004359 castor oil Substances 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000005720 sucrose Substances 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical group CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 235000010419 agar Nutrition 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- 238000007906 compression Methods 0.000 description 4
- 230000006835 compression Effects 0.000 description 4
- 235000015872 dietary supplement Nutrition 0.000 description 4
- 235000013355 food flavoring agent Nutrition 0.000 description 4
- 235000003599 food sweetener Nutrition 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- 150000004677 hydrates Chemical class 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 229940083466 soybean lecithin Drugs 0.000 description 4
- 239000003765 sweetening agent Substances 0.000 description 4
- 235000019156 vitamin B Nutrition 0.000 description 4
- 239000011720 vitamin B Substances 0.000 description 4
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 3
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 3
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- RADKZDMFGJYCBB-UHFFFAOYSA-N Pyridoxal Chemical compound CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000000691 measurement method Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 235000001968 nicotinic acid Nutrition 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 3
- 229940068968 polysorbate 80 Drugs 0.000 description 3
- 229920000053 polysorbate 80 Polymers 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 229960000984 tocofersolan Drugs 0.000 description 3
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 3
- 229940042585 tocopherol acetate Drugs 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- QZNNVYOVQUKYSC-JEDNCBNOSA-N (2s)-2-amino-3-(1h-imidazol-5-yl)propanoic acid;hydron;chloride Chemical compound Cl.OC(=O)[C@@H](N)CC1=CN=CN1 QZNNVYOVQUKYSC-JEDNCBNOSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- IELOKBJPULMYRW-IKTKBOKFSA-N 4-oxo-4-[[(2S)-2,5,7,8-tetramethyl-2-[(4S,8S)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl]oxy]butanoic acid Chemical compound CC(C)CCC[C@H](C)CCC[C@H](C)CCC[C@@](C)(CC1)Oc(c(C)c2C)c1c(C)c2OC(CCC(O)=O)=O IELOKBJPULMYRW-IKTKBOKFSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- 244000000626 Daucus carota Species 0.000 description 2
- 235000002767 Daucus carota Nutrition 0.000 description 2
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- QEKBRBCVWVLFHH-QAKUKHITSA-L Tocopherol calcium succinate Chemical compound [Ca+2].[O-]C(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C.[O-]C(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C QEKBRBCVWVLFHH-QAKUKHITSA-L 0.000 description 2
- 241000826860 Trapezium Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 229960003121 arginine Drugs 0.000 description 2
- 235000009697 arginine Nutrition 0.000 description 2
- 229960005261 aspartic acid Drugs 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 2
- 239000007979 citrate buffer Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000002826 coolant Substances 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- LIOJHMDIELWKFZ-OBBOLZQKSA-N ethyl [(z)-2-[(4-amino-2-methylpyrimidin-5-yl)methyl-formylamino]-5-ethoxycarbonyloxypent-2-en-3-yl]sulfanylformate;hydrochloride Chemical compound Cl.CCOC(=O)OCC\C(SC(=O)OCC)=C(/C)N(C=O)CC1=CN=C(C)N=C1N LIOJHMDIELWKFZ-OBBOLZQKSA-N 0.000 description 2
- CBOQJANXLMLOSS-UHFFFAOYSA-N ethyl vanillin Chemical compound CCOC1=CC(C=O)=CC=C1O CBOQJANXLMLOSS-UHFFFAOYSA-N 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229940097043 glucuronic acid Drugs 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- YOZNUFWCRFCGIH-BYFNXCQMSA-L hydroxocobalamin Chemical compound O[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O YOZNUFWCRFCGIH-BYFNXCQMSA-L 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 229960003646 lysine Drugs 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 235000006109 methionine Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- PXQPEWDEAKTCGB-UHFFFAOYSA-N orotic acid Chemical compound OC(=O)C1=CC(=O)NC(=O)N1 PXQPEWDEAKTCGB-UHFFFAOYSA-N 0.000 description 2
- 238000012858 packaging process Methods 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 229940068977 polysorbate 20 Drugs 0.000 description 2
- NHZMQXZHNVQTQA-UHFFFAOYSA-N pyridoxamine Chemical compound CC1=NC=C(CO)C(CN)=C1O NHZMQXZHNVQTQA-UHFFFAOYSA-N 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 150000003287 riboflavins Chemical class 0.000 description 2
- 229920002050 silicone resin Polymers 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000003549 soybean oil Chemical group 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 229960004799 tryptophan Drugs 0.000 description 2
- 229960004295 valine Drugs 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 239000002076 α-tocopherol Substances 0.000 description 2
- 235000004835 α-tocopherol Nutrition 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- AEQDJSLRWYMAQI-UHFFFAOYSA-N 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 description 1
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 description 1
- KWTQSFXGGICVPE-UHFFFAOYSA-N 2-amino-5-(diaminomethylideneamino)pentanoic acid;hydron;chloride Chemical compound Cl.OC(=O)C(N)CCCN=C(N)N KWTQSFXGGICVPE-UHFFFAOYSA-N 0.000 description 1
- LVFFZQQWIZURIO-UHFFFAOYSA-N 2-phenylbutanedioic acid Chemical compound OC(=O)CC(C(O)=O)C1=CC=CC=C1 LVFFZQQWIZURIO-UHFFFAOYSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- OHXPGWPVLFPUSM-KLRNGDHRSA-N 3,7,12-trioxo-5beta-cholanic acid Chemical compound C1CC(=O)C[C@H]2CC(=O)[C@H]3[C@@H]4CC[C@H]([C@@H](CCC(O)=O)C)[C@@]4(C)C(=O)C[C@@H]3[C@]21C OHXPGWPVLFPUSM-KLRNGDHRSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- IWXAZSAGYJHXPX-BCEWYCLDSA-N Bisbentiamine Chemical compound C=1C=CC=CC=1C(=O)OCC/C(SS\C(CCOC(=O)C=1C=CC=CC=1)=C(/C)N(CC=1C(=NC(C)=NC=1)N)C=O)=C(/C)N(C=O)CC1=CN=C(C)N=C1N IWXAZSAGYJHXPX-BCEWYCLDSA-N 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- IMAGLCGCHKGGLR-UHFFFAOYSA-M Choline orotate Chemical compound C[N+](C)(C)CCO.[O-]C(=O)C1=CC(=O)NC(=O)N1 IMAGLCGCHKGGLR-UHFFFAOYSA-M 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 244000160089 Crataegus cuneata Species 0.000 description 1
- 235000008440 Crataegus cuneata Nutrition 0.000 description 1
- 244000124209 Crocus sativus Species 0.000 description 1
- 235000015655 Crocus sativus Nutrition 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- UYUXSRADSPPKRZ-UHFFFAOYSA-N D-glucuronic acid gamma-lactone Natural products O=CC(O)C1OC(=O)C(O)C1O UYUXSRADSPPKRZ-UHFFFAOYSA-N 0.000 description 1
- UYUXSRADSPPKRZ-SKNVOMKLSA-N D-glucurono-6,3-lactone Chemical compound O=C[C@H](O)[C@H]1OC(=O)[C@@H](O)[C@H]1O UYUXSRADSPPKRZ-SKNVOMKLSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 239000004470 DL Methionine Substances 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- ILKBHIBYKSHTKQ-UHFFFAOYSA-N Diisopropylamine dichloroacetate Chemical compound OC(=O)C(Cl)Cl.CC(C)NC(C)C ILKBHIBYKSHTKQ-UHFFFAOYSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- CTKXFMQHOOWWEB-UHFFFAOYSA-N Ethylene oxide/propylene oxide copolymer Chemical compound CCCOC(C)COCCO CTKXFMQHOOWWEB-UHFFFAOYSA-N 0.000 description 1
- PMVSDNDAUGGCCE-TYYBGVCCSA-L Ferrous fumarate Chemical compound [Fe+2].[O-]C(=O)\C=C\C([O-])=O PMVSDNDAUGGCCE-TYYBGVCCSA-L 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- 235000019766 L-Lysine Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- IFQSXNOEEPCSLW-DKWTVANSSA-N L-cysteine hydrochloride Chemical compound Cl.SC[C@H](N)C(O)=O IFQSXNOEEPCSLW-DKWTVANSSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 229930182844 L-isoleucine Natural products 0.000 description 1
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 235000019596 Masking bitterness Nutrition 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002675 Polyoxyl Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- CEEQUQSGVRRXQI-UHFFFAOYSA-N Pyridoxal 5-phosphate monohydrate Chemical compound O.CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O CEEQUQSGVRRXQI-UHFFFAOYSA-N 0.000 description 1
- MJNIWUJSIGSWKK-BBANNHEPSA-N Riboflavin butyrate Chemical compound CCCC(=O)OC[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)CN1C2=CC(C)=C(C)C=C2N=C2C1=NC(=O)NC2=O MJNIWUJSIGSWKK-BBANNHEPSA-N 0.000 description 1
- 239000004283 Sodium sorbate Substances 0.000 description 1
- 239000004147 Sorbitan trioleate Substances 0.000 description 1
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- GZQCZDHGTYFJIF-LZWOXQAQSA-N [(2r,3s,4s)-5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] acetate Chemical compound CC(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=CC(C)=C(C)C=C2N=C2C1=NC(=O)NC2=O GZQCZDHGTYFJIF-LZWOXQAQSA-N 0.000 description 1
- VLSOAXRVHARBEQ-UHFFFAOYSA-N [4-fluoro-2-(hydroxymethyl)phenyl]methanol Chemical compound OCC1=CC=C(F)C=C1CO VLSOAXRVHARBEQ-UHFFFAOYSA-N 0.000 description 1
- PFZXGXCGOJDNRF-UHFFFAOYSA-N [5-hydroxy-4-(hydroxymethyl)-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(O)=C1CO PFZXGXCGOJDNRF-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 1
- RRNJROHIFSLGRA-JEDNCBNOSA-N acetic acid;(2s)-2,6-diaminohexanoic acid Chemical compound CC(O)=O.NCCCC[C@H](N)C(O)=O RRNJROHIFSLGRA-JEDNCBNOSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 239000002386 air freshener Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 229930002945 all-trans-retinaldehyde Natural products 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- WLDHEUZGFKACJH-UHFFFAOYSA-K amaranth Chemical compound [Na+].[Na+].[Na+].C12=CC=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(O)=C1N=NC1=CC=C(S([O-])(=O)=O)C2=CC=CC=C12 WLDHEUZGFKACJH-UHFFFAOYSA-K 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- PLKYGPRDCKGEJH-UHFFFAOYSA-N azane;2-hydroxypropane-1,2,3-tricarboxylic acid;iron Chemical compound N.[Fe].OC(=O)CC(O)(C(O)=O)CC(O)=O PLKYGPRDCKGEJH-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229950009892 bisbentiamine Drugs 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 230000000595 bitter masking effect Effects 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229940047036 calcium ascorbate Drugs 0.000 description 1
- 235000010376 calcium ascorbate Nutrition 0.000 description 1
- 239000011692 calcium ascorbate Substances 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- 239000004227 calcium gluconate Substances 0.000 description 1
- 235000013927 calcium gluconate Nutrition 0.000 description 1
- 229960004494 calcium gluconate Drugs 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- BLORRZQTHNGFTI-ZZMNMWMASA-L calcium-L-ascorbate Chemical compound [Ca+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] BLORRZQTHNGFTI-ZZMNMWMASA-L 0.000 description 1
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 1
- VPWAVWZPVGDNMN-UHFFFAOYSA-L calcium;2,3-dihydroxypropanoate Chemical compound [Ca+2].OCC(O)C([O-])=O.OCC(O)C([O-])=O VPWAVWZPVGDNMN-UHFFFAOYSA-L 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 229950008138 carmellose Drugs 0.000 description 1
- PHIQHXFUZVPYII-UHFFFAOYSA-N carnitine Chemical compound C[N+](C)(C)CC(O)CC([O-])=O PHIQHXFUZVPYII-UHFFFAOYSA-N 0.000 description 1
- 229960000678 carnitine chloride Drugs 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000007958 cherry flavor Substances 0.000 description 1
- 239000008370 chocolate flavor Substances 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- ASARMUCNOOHMLO-WLORSUFZSA-L cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2s)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O ASARMUCNOOHMLO-WLORSUFZSA-L 0.000 description 1
- ZIHHMGTYZOSFRC-UWWAPWIJSA-M cobamamide Chemical compound C1(/[C@](C)(CCC(=O)NC[C@H](C)OP(O)(=O)OC2[C@H]([C@H](O[C@@H]2CO)N2C3=CC(C)=C(C)C=C3N=C2)O)[C@@H](CC(N)=O)[C@]2(N1[Co+]C[C@@H]1[C@H]([C@@H](O)[C@@H](O1)N1C3=NC=NC(N)=C3N=C1)O)[H])=C(C)\C([C@H](C/1(C)C)CCC(N)=O)=N\C\1=C/C([C@H]([C@@]\1(CC(N)=O)C)CCC(N)=O)=N/C/1=C(C)\C1=N[C@]2(C)[C@@](C)(CC(N)=O)[C@@H]1CCC(N)=O ZIHHMGTYZOSFRC-UWWAPWIJSA-M 0.000 description 1
- 235000006279 cobamamide Nutrition 0.000 description 1
- 239000011789 cobamamide Substances 0.000 description 1
- 239000008373 coffee flavor Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960002997 dehydrocholic acid Drugs 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 229940084113 diisopropylamine dichloroacetate Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- IKALZAKZWHFNIC-JIZZDEOASA-L dipotassium;(2s)-2-aminobutanedioate Chemical compound [K+].[K+].[O-]C(=O)[C@@H](N)CC([O-])=O IKALZAKZWHFNIC-JIZZDEOASA-L 0.000 description 1
- YKZPPPNXRZHVGX-PXYKVGKMSA-L dipotassium;(2s)-2-aminobutanedioate;hydron;hydrate Chemical compound [H+].[H+].O.[K+].[K+].[O-]C(=O)[C@@H](N)CC([O-])=O.[O-]C(=O)[C@@H](N)CC([O-])=O YKZPPPNXRZHVGX-PXYKVGKMSA-L 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229940073505 ethyl vanillin Drugs 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000011773 ferrous fumarate Substances 0.000 description 1
- 235000002332 ferrous fumarate Nutrition 0.000 description 1
- 229960000225 ferrous fumarate Drugs 0.000 description 1
- VWWQXMAJTJZDQX-UYBVJOGSSA-N flavin adenine dinucleotide Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UYBVJOGSSA-N 0.000 description 1
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000000989 food dye Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 229940014259 gelatin Drugs 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000012812 general test Methods 0.000 description 1
- 229950002441 glucurolactone Drugs 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- LPTIRUACFKQDHZ-UHFFFAOYSA-N hexadecyl sulfate;hydron Chemical class CCCCCCCCCCCCCCCCOS(O)(=O)=O LPTIRUACFKQDHZ-UHFFFAOYSA-N 0.000 description 1
- 235000019534 high fructose corn syrup Nutrition 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 235000004867 hydroxocobalamin Nutrition 0.000 description 1
- 239000011704 hydroxocobalamin Substances 0.000 description 1
- 229960001103 hydroxocobalamin Drugs 0.000 description 1
- 229960005469 hydroxocobalamin acetate Drugs 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- DQOCFCZRZOAIBN-WZHZPDAFSA-L hydroxycobalamin Chemical compound O.[Co+2].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O DQOCFCZRZOAIBN-WZHZPDAFSA-L 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 1
- FCCDDURTIIUXBY-UHFFFAOYSA-N lipoamide Chemical compound NC(=O)CCCCC1CCSS1 FCCDDURTIIUXBY-UHFFFAOYSA-N 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229960001708 magnesium carbonate Drugs 0.000 description 1
- 235000014380 magnesium carbonate Nutrition 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- RXMQCXCANMAVIO-CEOVSRFSSA-L magnesium;(2s)-2-amino-4-hydroxy-4-oxobutanoate Chemical compound [H+].[H+].[Mg+2].[O-]C(=O)[C@@H](N)CC([O-])=O.[O-]C(=O)[C@@H](N)CC([O-])=O RXMQCXCANMAVIO-CEOVSRFSSA-L 0.000 description 1
- NFFJLMKHRCXLJO-DKWTVANSSA-L magnesium;(2s)-2-aminobutanedioate Chemical compound [Mg+2].[O-]C(=O)[C@@H](N)CC([O-])=O NFFJLMKHRCXLJO-DKWTVANSSA-L 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000002609 medium Chemical group 0.000 description 1
- 229940057917 medium chain triglycerides Drugs 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N methionine Chemical compound CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
- JEWJRMKHSMTXPP-BYFNXCQMSA-M methylcobalamin Chemical compound C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O JEWJRMKHSMTXPP-BYFNXCQMSA-M 0.000 description 1
- 235000007672 methylcobalamin Nutrition 0.000 description 1
- 239000011585 methylcobalamin Substances 0.000 description 1
- 239000008368 mint flavor Substances 0.000 description 1
- TZBAVQKIEKDGFH-UHFFFAOYSA-N n-[2-(diethylamino)ethyl]-1-benzothiophene-2-carboxamide;hydrochloride Chemical compound [Cl-].C1=CC=C2SC(C(=O)NCC[NH+](CC)CC)=CC2=C1 TZBAVQKIEKDGFH-UHFFFAOYSA-N 0.000 description 1
- 150000002814 niacins Chemical class 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000007968 orange flavor Substances 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 229960005010 orotic acid Drugs 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 150000002948 pantothenic acids Chemical class 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 125000001095 phosphatidyl group Chemical group 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920001993 poloxamer 188 Polymers 0.000 description 1
- 229940044519 poloxamer 188 Drugs 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229940068988 potassium aspartate Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 229940088417 precipitated calcium carbonate Drugs 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 229960003581 pyridoxal Drugs 0.000 description 1
- 235000008164 pyridoxal Nutrition 0.000 description 1
- 239000011674 pyridoxal Substances 0.000 description 1
- FCHXJFJNDJXENQ-UHFFFAOYSA-N pyridoxal hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(C=O)=C1O FCHXJFJNDJXENQ-UHFFFAOYSA-N 0.000 description 1
- 235000008151 pyridoxamine Nutrition 0.000 description 1
- 239000011699 pyridoxamine Substances 0.000 description 1
- ZMJGSOSNSPKHNH-UHFFFAOYSA-N pyridoxamine 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(CN)=C1O ZMJGSOSNSPKHNH-UHFFFAOYSA-N 0.000 description 1
- HNWCOANXZNKMLR-UHFFFAOYSA-N pyridoxamine dihydrochloride Chemical compound Cl.Cl.CC1=NC=C(CO)C(CN)=C1O HNWCOANXZNKMLR-UHFFFAOYSA-N 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- WHOMFKWHIQZTHY-UHFFFAOYSA-N pyridoxine 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(CO)=C1O WHOMFKWHIQZTHY-UHFFFAOYSA-N 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 235000020945 retinal Nutrition 0.000 description 1
- 239000011604 retinal Substances 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- NCYCYZXNIZJOKI-OVSJKPMPSA-N retinal group Chemical group C\C(=C/C=O)\C=C\C=C(\C=C\C1=C(CCCC1(C)C)C)/C NCYCYZXNIZJOKI-OVSJKPMPSA-N 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 229950001574 riboflavin phosphate Drugs 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000013974 saffron Nutrition 0.000 description 1
- 239000004248 saffron Substances 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- GQTHJBOWLPZUOI-FJXQXJEOSA-M sodium D-pantothenate Chemical compound [Na+].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O GQTHJBOWLPZUOI-FJXQXJEOSA-M 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical class [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 239000000176 sodium gluconate Substances 0.000 description 1
- 235000012207 sodium gluconate Nutrition 0.000 description 1
- 229940005574 sodium gluconate Drugs 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 229940068459 sodium pantothenate Drugs 0.000 description 1
- LROWVYNUWKVTCU-STWYSWDKSA-M sodium sorbate Chemical compound [Na+].C\C=C\C=C\C([O-])=O LROWVYNUWKVTCU-STWYSWDKSA-M 0.000 description 1
- 235000019250 sodium sorbate Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- WRZYGPIFICWRCG-OOFFSTKBSA-M sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4s,5s,6s)-2-[[(3s,4ar,6ar,6bs,8as,11s,12ar,14ar,14bs)-11-carboxylato-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1h-picen-3-yl]oxy]-6-carboxylato-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trih Chemical compound [Na+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O WRZYGPIFICWRCG-OOFFSTKBSA-M 0.000 description 1
- LQVGUKOCMOKKJU-QPVGXXQTSA-M sodium;[(2r,3s,4s)-5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] hydrogen phosphate;dihydrate Chemical compound O.O.[Na+].OP(=O)([O-])OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O LQVGUKOCMOKKJU-QPVGXXQTSA-M 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 235000019337 sorbitan trioleate Nutrition 0.000 description 1
- 229960000391 sorbitan trioleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- RUDATBOHQWOJDD-UZVSRGJWSA-N ursodeoxycholic acid Chemical compound C([C@H]1C[C@@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-UZVSRGJWSA-N 0.000 description 1
- 229960001661 ursodiol Drugs 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 239000009538 yokuinin Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
本発明は、ビタミンB1類を含有する経口ゲル状組成物に関する。 The present invention relates to an oral gel composition containing B vitamins 1 .
ビタミンB1類は、生体に対する様々な有用性を有することが知られており、経口摂取される医薬品、医薬部外品及び食品等において広く用いられている。
ビタミンB1類を十分量で摂取可能にする形態としては、主に錠剤や飲料などの形態が好適に採用されているが、近年、流動性のある粘稠なゲル状の経口製剤もその形態として採用される場合が増加している。
このようなゲル状製剤が採用される背景には、特に先進国における高齢者の増加に伴う嚥下障害者の増加に関連して、投与若しくは摂取及び嚥下が容易である形態が消費者に好まれていることや、短時間で簡便に摂取が可能でありながら、空腹感を軽減できる形態が好まれていること等の理由が存在していると考えられる。
Vitamin B 1 class are known to have various utilities for biological, pharmaceutical products taken orally, it is widely used in the quasi-drug and foods.
Vitamin B 1 class of the form to enable ingested in sufficient amounts, primarily but form such as a tablet or beverage is preferably employed, in recent years, also its form viscous gel oral formulations having fluidity The number of cases where it is adopted as is increasing.
Behind the adoption of such gel-like preparations, consumers prefer a form that is easy to administer or ingest and swallow, especially in relation to the increase in dysphagia associated with the increase in the elderly in developed countries. It is considered that there are reasons such as the fact that the drug can be easily ingested in a short time and a form that can reduce the feeling of hunger is preferred.
ビタミンB1類を含有する経口ゲル状製剤に近い公知技術としては、0.01〜0.5重量%のビタミンB1類、及び0.5〜30重量%のコンドロイチン硫酸塩を含有する経口ゼリー剤(特許文献1)が挙げられるが、該経口ゼリー剤は、流動性の無い成形したゲル状の製剤であり、液状または流動性のある粘稠なゲル状の製剤ではない。 Known techniques closer to oral gel formulation containing vitamin B 1 class, 0.01-0.5 wt% of vitamin B 1 class, and oral jelly containing 0.5 to 30% by weight of chondroitin sulfate An agent (Patent Document 1) can be mentioned, but the oral jelly agent is a non-fluid, molded gel-like preparation, not a liquid or a fluid, viscous gel-like preparation.
本発明者らの検討によれば、ビタミンB1類を安定に含有する経口ゲル状組成物の実現、及びゲル状形態が安定な、特に酸性下における製造時の熱負荷においても、経時的な離水が少なく、所望の食感(硬さ)が安定なビタミンB1類を含有する経口ゲル状組成物の実現はそれぞれ困難であり、ビタミンB1類を安定に含有し、尚且つゲル状形態も安定な経口ゲル状組成物の実現は更に困難である。 According to the studies of the present inventors, realizing the oral gel composition stably containing vitamin B 1 class, and gel-like forms are stable, even in the particular thermal load during production in acidic conditions, a time water separation is small, the desired implementation of the texture (firmness) of the oral gel compositions containing stable vitamins B 1 class are each difficult, vitamin B 1 class contains stable, besides a form of gel However, it is even more difficult to realize a stable oral gel composition.
従い、本発明においては、ビタミンB1類を安定に含有し、且つゲル状形態も安定な、特に酸性下における製造時の熱負荷においても、経時的な離水が少なく、食感(硬さ)が安定な経口ゲル状組成物の提供を目的とする。 Therefore, in the present invention contains a vitamin B 1 class stability, and gel-like forms are also stable, in particular also in the thermal load during production in acidic conditions, less temporal water separation, texture (hardness) It is an object of the present invention to provide a stable oral gel composition.
本発明者らは、鋭意検討の結果、ビタミンB1類、及びジェランガムを含有し、且つビタミンB1類の1質量部に対して、ジェランガムを10〜2000質量部の範囲内で含有することなどを特徴とする経口ゲル状組成物によって、前記した課題が解決できることを見出し、本発明を完成するに至った。 The present inventors have intensive studies results, vitamin B 1 class, and contains a gellan gum, and with respect to 1 part by weight of vitamin B 1 class, the gellan gum such as that contained in the range of 10 to 2000 parts by weight It was found that the above-mentioned problems can be solved by the oral gel-like composition characterized by the above, and the present invention has been completed.
すなわち、本発明は、以下の態様を含む。
[1] ビタミンB1類、及びジェランガムを含有し、且つビタミンB1類の1質量部に対して、ジェランガムを10〜2000質量部の範囲内で含有することを特徴とする経口ゲル状組成物。
[2] ビタミンB1類、及びジェランガムを含有し、且つジェランガムの含有量が3.0g/L未満であることを特徴とする経口ゲル状組成物。
[3] ビタミンB1類、及びジェランガムを含有し、且つpHが2.5〜3.8の範囲内であることを特徴とする経口ゲル状組成物。
[4] 医薬品または医薬部外品として用いられる、上記[1]〜[3]いずれか一項に記載の経口ゲル状組成物。
[5] ビタミンB1類が、チアミン塩酸塩、チアミン硝酸塩、ビスチアミン硝酸塩、チアミンジスルフィド、チアミンジセチル硫酸エステル塩、ジセチアミン塩酸塩、フルスルチアミン、フルスルチアミン塩酸塩、オクトチアミン、シコチアミン、ビスイブチアミン、ビスベンチアミン、プロスルチアミン、及びベンフォチアミンからなる群より選択される1種以上である、上記[1]〜[4]いずれか一項に記載の経口ゲル状組成物。
That is, the present invention includes the following aspects.
[1] An oral gel-like composition containing vitamin B 1 and gellan gum, and containing gellan gum in the range of 10 to 2000 parts by mass with respect to 1 part by mass of vitamin B 1 . ..
[2] An oral gel-like composition containing vitamin B 1 and gellan gum and having a gellan gum content of less than 3.0 g / L.
[3] Vitamin B 1 class, and contains a gellan gum, and oral gel compositions wherein the pH is in the range of 2.5 to 3.8.
[4] The oral gel composition according to any one of the above [1] to [3], which is used as a drug or a quasi drug.
[5] vitamin B 1 class is thiamine hydrochloride, thiamine nitrate, Bisuchiamin nitrate, thiamine disulfide, thiamine dicetyl sulfate ester salts, dicethiamine hydrochloride, fursultiamine, fursultiamine hydrochloride, oct thiamin, Shikochiamin, Bisuibu The oral gel-like composition according to any one of the above [1] to [4], which is one or more selected from the group consisting of thiamine, bisbenchamine, prosultiamine, and benfothiamine.
本発明によれば、ビタミンB1類を安定に含有し、且つゲル状形態も安定な経口ゲル状組成物が提供される。特に、本発明によれば、酸性下における製造時の熱負荷においても、経時的な離水が少なく、食感(硬さ)が安定な経口ゲル状組成物が提供される。 According to the present invention contains a vitamin B 1 class stable, stable oral gel composition is provided and also a form of gel. In particular, according to the present invention, there is provided an oral gel-like composition having a stable texture (hardness) with little water separation over time even under a heat load during production under acidic conditions.
用語
本明細書中、用語「ゲル状組成物」とは、固体であるゲル組成物と区別して、流動性のある粘稠な液体組成物を意味する。
Terms As used herein, the term "gel composition" means a fluid, viscous liquid composition to distinguish it from a solid gel composition.
本明細書中の記号及び略号は、特に限定のない限り、本発明が属する技術分野において通常用いられる意味に理解される。
本明細書中に記載されている工程、処理、又は操作は、特に限定されない限り、室温で実施される。本明細書中、室温は、10〜35℃の範囲内の温度を意味する。
Unless otherwise specified, the symbols and abbreviations in the present specification are understood to have common meanings in the technical field to which the present invention belongs.
The steps, treatments, or operations described herein are performed at room temperature unless otherwise specified. In the present specification, room temperature means a temperature in the range of 10 to 35 ° C.
経口ゲル状組成物
本発明の経口ゲル状組成物は、ビタミンB1類、及びジェランガムを含有する。
以下、本発明の経口ゲル状組成物に含有する成分、及び含有してもよい成分について説明する。
Oral gel compositions oral gel composition of the present invention, vitamin B 1 class, and contains a gellan gum.
Hereinafter, the components contained in the oral gel composition of the present invention and the components that may be contained will be described.
・ビタミンB 1 類
本発明において用いられるビタミンB1類の例は、チアミン、ビスチアミン、チアミンジスルフィド、ジセチアミン、フルスルチアミン、オクトチアミン、シコチアミン、ビスイブチアミン、ビスベンチアミン、プロスルチアミン、及びベンフォチアミン、並びにそれらの塩、溶媒和物(例:水和物)、並びに塩の溶媒和物(例:水和物)を包含する。当該塩の例は、塩酸塩、硝酸塩、及びセチル硫酸塩を包含する。
Vitamin B 1 class examples of vitamin B 1 class used in the present invention, thiamine, Bisuchiamin, thiamine disulfide, dicethiamine, fursultiamine, oct thiamine, Shikochiamin, bis Eve thiamine, bisbentiamine, prosultiamine, and Ben Includes fotiamines and their salts, solvates (eg hydrates), and hydrates of salts (eg hydrates). Examples of such salts include hydrochlorides, nitrates, and cetyl sulfates.
当該ビタミンB1類は、好適に、チアミン塩酸塩、チアミン硝酸塩、ビスチアミン硝酸塩、チアミンジスルフィド、チアミンジセチル硫酸エステル塩、ジセチアミン塩酸塩、フルスルチアミン、フルスルチアミン塩酸塩、オクトチアミン、シコチアミン、ビスイブチアミン、ビスベンチアミン、プロスルチアミン、及びベンフォチアミンからなる群より選択される1種以上であることができる。
本発明において特に好適に用いられるビタミンB1類は、フルスルチアミン又はその塩酸塩である。
The vitamin B 1 class is suitably, thiamine hydrochloride, thiamine nitrate, Bisuchiamin nitrate, thiamine disulfide, thiamine dicetyl sulfate ester salts, dicethiamine hydrochloride, fursultiamine, fursultiamine hydrochloride, oct thiamin, Shikochiamin, bis It can be one or more selected from the group consisting of ibutyamine, bisbenchamine, prosultiamine, and benfothiamine.
Vitamin B 1 class, particularly preferably used in the present invention is a Furusuruchiamin or its hydrochloride salt.
本発明の経口ゲル状組成物におけるビタミンB1類の配合量は、組成物全体に対して、約0.00005〜0.5w/v%、好ましくは約0.0002〜0.25w/v%、より好ましくは約0.0005〜0.05w/v%、さらに好ましくは約0.001〜0.03w/v%である。 The blending amount of B vitamins 1 in the oral gel composition of the present invention is about 0.00005 to 0.5 w / v%, preferably about 0.0002 to 0.25 w / v%, based on the entire composition. , More preferably about 0.0005 to 0.05 w / v%, still more preferably about 0.001 to 0.03 w / v%.
・ビタミンB 1 類以外の有効成分
本発明の経口ゲル状組成物においては、本発明の効果を阻害しない限り、ビタミンB1類以外の有効成分、例えばビタミンB1類以外のビタミン類、アミノ酸類等をはじめとする、医薬品、医薬部外品、保健機能食品(例:機能性表示食品、栄養機能食品、特定保健用食品)、又は一般食品(例:栄養補助食品、健康補助食品、栄養調整食品)等において用いられる、その他の有効成分の一種以上をさらに含有してもよい。
· In the oral gel composition of the active ingredient present invention other than vitamin B 1 class, as long as it does not inhibit the effects of the present invention, the active ingredient other than vitamin B 1 class, for example, vitamin B 1 class other than vitamins, amino acids Pharmaceuticals, non-pharmaceutical products, foods with health claims (eg foods with functional claims, foods with nutritional claims, foods for specified health use), or general foods (eg dietary supplements, dietary supplements, nutritional adjustments) It may further contain one or more of other active ingredients used in foods) and the like.
前記ビタミンB1類以外のビタミン類の例は、ビタミンA類(例:レチノール、レチノイン酸、レチナール、レチノール酢酸エステル、レチノールパルミチン酸エステル、ビタミンA油、肝油、強肝油)、ビタミンB2類[例:リボフラビン、リボフラビン誘導体(例:リボフラビンリン酸エステル、リボフラビン酢酸エステル、リボフラビン酪酸エステル等のリボフラビンエステル;フラビンアデニンジヌクレオチドナトリウム等)及びその塩(例:リボフラビンリン酸エステルナトリウム)]、ビタミンB6類[例:ピリドキシン、ピリドキサミン、ピリドキサール、それらの誘導体(例:ピリドキシンリン酸エステル、ピリドキサールリン酸エステル水和物、ピリドキサミンリン酸エステル、ピリドキシンパルミチン酸エステル)及びその塩(例:ピリドキシン塩酸塩、ピリドキサール塩酸塩、ピリドキサミン二塩酸塩)]、ビタミンB12類(例:コバラミン、シアノコバラミン、メチルコバラミン、アデノシルコバラミン、ヒドロキソコバラミン、ヒドロキソコバラミン塩酸塩、ヒドロキソコバラミン酢酸塩)、ビタミンC類(例:アスコルビン酸、アスコルビン酸リン酸エステルマグネシウム、アスコルビン酸ナトリウム、アスコルビン酸カルシウム、酢酸トコフェロールアスコルビン酸エステル)、ビタミンD類(例:エルゴカルシフェロール、コレカルシフェロール)、ビタミンE類(例:コハク酸d−α−トコフェロール、コハク酸dl−α−トコフェロール、コハク酸dl−α−トコフェロールカルシウム、コハク酸d−α−トコフェロールカルシウム、コハク酸トコフェロールカルシウム、酢酸d−α−トコフェロール、酢酸dl−α−トコフェロール、d−α−トコフェロール、dl−α−トコフェロール)、ナイアシン類(例:ニコチン酸、ニコチン酸アミド)、パントテン酸類(例:パンテノール、パントテン酸カルシウム、パントテン酸ナトリウム)、及びその他のビタミン類(例:ビタミンK類、ビオチン、葉酸、γ−オリザノール)、並びにそれらの組合せを包含する。 Examples of vitamins other than vitamin B 1 include vitamin A (eg, retinol, retinoic acid, retinal, retinol acetate, retinol palmitate, vitamin A oil, liver oil, strong liver oil), vitamin B 2 [ Examples: riboflavin, riboflavin derivatives (eg, riboflavin esters such as riboflavin phosphate, riboflavin acetate, riboflavin butyrate; riboflavin ester such as flavin adenindinucleotide sodium) and salts thereof (eg, sodium riboflavin phosphate)], vitamin B 6 Classes [eg, pyridoxin, pyridoxamine, pyridoxal, derivatives thereof (eg, pyridoxin phosphate, pyridoxal phosphate hydrate, pyridoxamine phosphate, pyridoxin palmitate) and salts thereof (eg, pyridoxin hydrochloride) , pyridoxal hydrochloride, pyridoxamine dihydrochloride), vitamin B 12 compound (e.g. cobalamin, cyanocobalamin, methylcobalamin, adenosylcobalamin, hydroxocobalamin, hydroxocobalamin hydrochloride, hydroxocobalamin acetate), vitamin C (e.g. Ascorbic acid, magnesium ascorbic acid phosphate, sodium ascorbate, calcium ascorbate, tocopherol acetate ascorbic acid ester), vitamin Ds (eg ergocalciferol, cholecalciferol), vitamin Es (eg d-succinate) α-tocopherol, dl-α-tocopherol succinate, dl-α-tocopherol succinate, d-α-tocopherol calcium succinate, tocopherol calcium succinate, d-α-tocopherol acetate, dl-α-tocopherol acetate, d -Α-tocopherol, dl-α-tocopherol), niacins (eg nicotinic acid, nicotinic acid amide), pantothenic acids (eg pantenol, calcium pantothenate, sodium pantothenate), and other vitamins (eg nicotinate) Vitamin Ks, biotin, folic acid, γ-orizanol), and combinations thereof.
前記アミノ酸類の例は、アスパラギン酸(例:L−アスパラギン酸、L−アスパラギン酸カリウム、L−アスパラギン酸ナトリウム、L−アスパラギン酸マグネシウム、アスパラギン酸カリウム・マグネシウム等量混合物)、グルタミン酸(例:L−グルタミン酸)、アルギニン(例:L−アルギニン、L−アルギニン塩酸塩)、トリプトファン(例:L−トリプトファン)、リシン(例:L−リシン塩酸塩、L−リシン酢酸塩)、グリシン、ロイシン(例:L−ロイシン)、イソロイシン(例:L−イソロイシン)、トレオニン(例:L−トレオニン)、システイン(例:L−システイン、L−システイン塩酸塩、L−システイン塩酸塩水和物)、バリン(例:L−バリン)、ヒスチジン(例:L−ヒスチジン、L−ヒスチジン塩酸塩、L−ヒスチジン塩酸塩水和物)、及びメチオニン(例:DL−メチオニン)、並びにそれらの組合せを包含する。 Examples of the amino acids include aspartic acid (eg, L-aspartic acid, potassium L-aspartate, sodium L-aspartate, magnesium L-aspartate, potassium aspartate / magnesium equal amount mixture), glutamate (eg L). -Glutamic acid), arginine (eg L-arginine, L-arginine hydrochloride), tryptophan (eg L-tryptophan), lysine (eg L-lysine hydrochloride, L-lysine acetate), glycine, leucine (eg) : L-lysine), isoleucine (eg L-isoleucine), threonine (eg L-thionine), cysteine (eg L-cysteine, L-cysteine hydrochloride, L-cysteine hydrochloride hydrate), valine (eg) : L-valine), histidine (eg L-lysine, L-histidine hydrochloride, L-histidine hydrochloride hydrate), and methionine (eg DL-methionine), and combinations thereof.
前記その他の有効成分の他の例は、タウリン(アミノエチルスルホン酸)、ウルソデスオキシコール酸、塩化カルニチン、オロチン酸、オロチン酸コリン、ガンマ−オリザノール、クエン酸カルシウム、グリセリン酸カルシウム、グルコン酸カルシウム、ジクロロ酢酸ジイソプロピルアミン、炭酸カルシウム、沈降炭酸カルシウム、乳酸カルシウム、リン酸水素カルシウム、無水リン酸水素カルシウム、クエン酸鉄アンモニウム、フマル酸第一鉄、グルクロノラクトン、グルクロン酸、グルクロン酸アミド、カフェイン、無水カフェイン、コンドロイチン硫酸ナトリウム、イノシトール、グリチルリチン酸、グリチルリチン酸ナトリウム、グルコン酸ナトリウム、重酒石酸コリン、炭酸マグネシウム、チオクト酸、チオクト酸アミド、デヒドロコール酸、パンテチン、ヨークレシチン、ルチン、及び生薬(例:アセンヤク、ウイキョウ、エゾウコギ、オウセイ、加工ダイサン、ガラナ、カンゾウ、クコシ、ケイヒ、コウジン、サフラン、サンザシ、サンヤク、シャクヤク、シュクシャ、ショウキョウ、ジョテイシ、セイヨウサンザシ、タイソウ、チョウジ、チンピ、トウキ、トシシ、トチュウ、ニクジュヨウ、ニンジン、ニンニク、ブクリョウ、ムイラブアマ、モッコウ、ヤクチ、ヨクイニン、リュウガンニク、ロクジョウ、カイバ、ニクジュヨウ、ハゲキテン、オウギ、ビャクジュツ、ローヤルゼリー)、並びにそれらの組合せを包含する。 Other examples of the other active ingredients include taurine (aminoethylsulfonic acid), ursodesoxycholic acid, carnitine chloride, orotic acid, choline orotate, gamma-orizanol, calcium citrate, calcium glycerate, calcium gluconate, Diisopropylamine dichloroacetate, calcium carbonate, precipitated calcium carbonate, calcium lactate, calcium hydrogen phosphate, anhydrous calcium hydrogen phosphate, ammonium iron citrate, ferrous fumarate, glucuronolactone, glucuronic acid, glucuronic acid amide, caffeine , Anhydrous caffeine, sodium chondroitin sulfate, inositol, glycyrrhizinic acid, sodium glycyrrhizinate, sodium gluconate, choline heavy tartrate, magnesium carbonate, thioctic acid, thioctic acid amide, dehydrocholic acid, pantetin, yoke lecithin, rutin, and crude drug ( Examples: Asenyaku, Uikyo, Ezokogi, Osei, Processed Daisan, Galana, Kanzo, Kukoshi, Keihi, Kojin, Saffron, Sanzashi, Sanyaku, Shakuyaku, Sukusha, Shokyo, Joteishi, Seiyousanzashi, Taiso , Tochu, Nikujuyo, Carrot, Carrot, Bukuryo, Muirabuama, Mokko, Yakuchi, Yokuinin, Ryugannik, Rokujo, Kaiba, Nikujuyo, Hagekiten, Ougi, Byakujutsu, Royal Jelly), and combinations thereof.
これらビタミンB1類以外の有効成分の量は、その種類、及び目的等に応じて、適宜設定される。 The amount of active ingredients other than these vitamins B 1 class, the type, and depending on the purpose or the like is appropriately set.
・ジェランガム
本発明においては、様々なジェランガムを好適に使用することができる。例えば、ネイティブ型(HA)ジェランガム、脱アシル型(LA)ジェランガムなどを使用することができる。脱アシル型ジェランガムの場合、一般に脱アシル型ジェランガムをゲル化させるのに使用される適度な量のカルシウムイオンと併用して使用することが好ましい。
このようなジェランガムは、商業的に入手可能であり、例えば、三栄源エフエフアイから販売される各種ネイティブ型(HA)ジェランガム及び脱アシル型(LA)ジェランガム、ケルコゲル(R)(製品名、CP Kelco U.S., Inc.)などが挙げられる。
-Gellan gum In the present invention, various gellan gums can be preferably used. For example, native type (HA) gellan gum, deacylated (LA) gellan gum and the like can be used. In the case of deacylated gellan gum, it is preferable to use it in combination with an appropriate amount of calcium ions generally used for gelling the deacylated gellan gum.
Such gellan gums are commercially available, for example, various native (HA) gellan gums and deacylated (LA) gellan gums, kercogels (R) (product name, CP Kelco ) sold by Saneigen FFI. US, Inc.) and so on.
本発明者らは鋭意検討の結果、ビタミンB1類の1質量部に対して、ジェランガムを10〜2000質量部の範囲内で含有することが望ましいことを見出した。
従い、本発明で用いられるジェランガムの含有量としては、ビタミンB1類の1質量部に対して、10〜2000質量部の範囲内が好ましく、15〜1500質量部の範囲内がより好ましく、20〜1000質量部の範囲内が特に好ましい。
We, the present inventors have assiduously studied the results, with respect to 1 part by weight of vitamin B 1 class, we have found that it is desirable to contain in the range of 10 to 2000 parts by weight of gellan gum.
Therefore, the content of gellan gum used in the present invention, with respect to 1 part by weight of vitamin B 1 class, preferably in the range of 10 to 2000 parts by weight, more preferably in the range of 15 to 1,500 parts by weight, 20 It is particularly preferably in the range of ~ 1000 parts by mass.
また、本発明の経口ゲル状組成物におけるジェランガムの含有量は、組成物全体に対して、好ましくは3.0g/L未満、より好ましくは2.8g/L未満、更に好ましくは0.5g/L〜2.5g/Lである。 The content of gellan gum in the oral gel-like composition of the present invention is preferably less than 3.0 g / L, more preferably less than 2.8 g / L, still more preferably 0.5 g / L, based on the entire composition. It is L to 2.5 g / L.
・ジェランガム以外の添加成分
本発明の経口ゲル状組成物においては、本発明の効果を阻害しない限り、前記成分に加えて、他の成分、例えば、一般的に経口ゲル状組成物に添加可能な成分(例:甘味剤、矯味剤、防腐剤、保存剤、着香剤、芳香剤、清涼化剤、界面活性剤、可溶化剤、乳化剤、溶剤、pH調節剤、緩衝剤、懸濁剤、着色剤、安定化剤、消泡剤、溶解補助剤、苦味マスキング剤、ジェランガム以外の粘稠剤)の一種以上を含有してもよい。
-Additional components other than gellan gum In the oral gel-like composition of the present invention, other components, for example, generally an oral gel-like composition, can be added in addition to the above-mentioned components as long as the effects of the present invention are not impaired. Ingredients (eg sweeteners, flavoring agents, preservatives, preservatives, flavoring agents, air fresheners, cooling agents, surfactants, solubilizers, emulsifiers, solvents, pH adjusters, buffers, suspending agents, It may contain one or more of a colorant, a stabilizer, a defoaming agent, a solubilizing agent, a bitterness masking agent, and a thickening agent other than gellan gum).
甘味剤の例は、糖類(例:ブドウ糖、ガラクトース、果糖、ショ糖、乳糖、麦芽糖、異性化糖、液糖、転化型液糖、トレハロース)、多糖類(例:オリゴ糖、デンプン)、糖アルコール類(例:エリスリトール、キシリトール、マルチトール、ソルビトール、還元麦芽糖水飴、粉末還元麦芽糖水飴)、高甘味度甘味料(例:アセスルファムカリウム)及び非糖質甘味料(例:スクラロース、ステビア抽出物、サッカリン、アスパルテーム)、並びにそれらの組合せを包含する。
矯味剤の例は、クエン酸又はその水和物、クエン酸ナトリウム、リンゴ酸(例:DL−リンゴ酸)等の酸味剤、及び果汁、並びにそれらの組合せを包含する。
防腐剤又は保存剤の例は、安息香酸、安息香酸ナトリウム、ソルビン酸ナトリウム、及びパラベン類(例:パラオキシ安息香酸エチル、パラオキシ安息香酸ブチル、パラオキシ安息香酸プロピル)、並びにそれらの組合せを包含する。
着香剤、芳香剤又は清涼化剤の例は、オレンジ油、メントール、バニリン及びその誘導体(例:エチルバニリン)、及び各種香料(例:ストロベリーフレーバー、チェリーフレーバー、オレンジフレーバー、グレープフルーツフレーバー、アップルフレーバー、レモンフレーバー、グレープフレーバー、コーヒーフレーバー、ブラックティーフレーバー、ビターフレーバー、ハーブミントフレーバー、チョコレートフレーバー、薬味酒フレーバー)、並びにそれらの組合せを包含する。
界面活性剤の例は、ショ糖脂肪酸エステル、プロピレングリコール、ポリオキシエチレン(160)ポリオキシプロピレン(30)グリコール(ポロクサマー188)、ポリオキシエチレン硬化ヒマシ油類(例:ポリオキシエチレン硬化ヒマシ油60)、ポリソルベート20、及びポリソルベート80、並びにそれらの組合せを包含する。
可溶化剤の例は、精製大豆レシチン、大豆レシチン、ダイズ油、中鎖脂肪酸トリグリセリド、マクロゴール4000、マクロゴール6000、流動パラフィン、ショ糖脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油類、及びポリソルベート80、並びにそれらの組合せを包含する。
乳化剤の例は、ショ糖脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油類、ポリソルベート20、ポリソルベート80、精製大豆レシチン、大豆レシチン、中鎖脂肪酸トリグリセリド、及び流動パラフィン、並びにそれらの組合せを包含する。
溶剤の例は、水(例:精製水)、エタノール、プロピレングリコール、オリーブ油、ゴマ油、ヒマシ油、ダイズ油、及び流動パラフィンを包含する。
pH調節剤又は緩衝剤の例は、リン酸、乳酸、酢酸、炭酸及びそれらの塩、塩酸、水酸化ナトリウム、水酸化カリウム、クエン酸緩衝液(0.2M)、及び炭酸水素ナトリウム、並びにそれらの組合せを包含する。
懸濁剤の例は、アラビアゴム、結晶セルロース、ビーガム、キサンタンガム、グァーガム、ゼラチン、メトロース及びその塩、カルメロース及びその塩、並びにそれらの組合せを包含する。
着色剤の例は、カラメル、β−カロチン、及び各種食用色素(例:食用黄色1号、食用赤色2号)、並びにそれらの組合せを包含する。
安定化剤の例は、シリコーン樹脂、グリセリン、エデト酸の塩、塩化ナトリウム、及びピロ亜硫酸の塩、並びにそれらの組合せを包含する。
消泡剤の例は、シリコーン樹脂、シリコーン油、エタノール、グリセリン脂肪酸エステル、ジメチルポリシロキサン、ショ糖脂肪酸エステル、ステアリル酸ポリオキシル、ソスルビタン脂肪酸エステル、トリオレイン酸ソルビタン、及びポリソルベート80、並びにそれらの組合せを包含する。
溶解補助剤の例は、プロピレングリコール、シクロデキストリン、及びアルギニン、並びにそれらの組合せを包含する。
苦味マスキング剤の例は、フォスファチジル類[例:BMI−60(製品名、花王)]を包含する。
ジェランガム以外の粘稠剤の例は、寒天、キサンタンガム、及びグァーガム並びにそれらの組合せを包含する。
Examples of sweeteners are sugars (eg glucose, galactose, fructose, sucrose, lactose, maltose, high fructose corn syrup, liquid sugar, converted liquid sugar, trehalose), polysaccharides (eg oligosaccharides, starch), sugars. Alcohols (eg erythritol, xylitol, martitol, sorbitol, reduced maltose syrup, powdered reduced maltose syrup), high-sweetness sweeteners (eg assesulfam potassium) and non-sugar sweeteners (eg sclarose, stevia extract, Includes saccharin, aspartame), and combinations thereof.
Examples of flavoring agents include citric acid or hydrates thereof, acidulants such as sodium citrate, malic acid (eg, DL-malic acid), and fruit juices, and combinations thereof.
Examples of preservatives or preservatives include benzoic acid, sodium benzoate, sodium sorbate, and parabens (eg, ethyl paraoxybenzoate, butyl paraoxybenzoate, propyl paraoxybenzoate), and combinations thereof.
Examples of flavoring agents, fragrances or cooling agents include orange oil, menthol, vanillin and its derivatives (eg ethylvanillin), and various flavors (eg strawberry flavor, cherry flavor, orange flavor, grapefruit flavor, apple flavor). , Lemon flavor, grape flavor, coffee flavor, black tea flavor, bitter flavor, herb mint flavor, chocolate flavor, flavored sake flavor), and combinations thereof.
Examples of surfactants are sucrose fatty acid ester, propylene glycol, polyoxyethylene (160) polyoxypropylene (30) glycol (poloxamer 188), polyoxyethylene hydrogenated castor oil (eg, polyoxyethylene hydrogenated castor oil 60). ), Polysorbate 20, and Polysorbate 80, and combinations thereof.
Examples of solubilizers include purified soybean lecithin, soybean lecithin, soybean oil, medium chain triglyceride, macrogol 4000, macrogol 6000, liquid paraffin, sucrose fatty acid ester, polyoxyethylene hydrogenated castor oil, and polysolvate 80. And include combinations thereof.
Examples of emulsifiers include sucrose fatty acid esters, polyoxyethylene hydrogenated castor oils, polysorbate 20, polysorbate 80, refined soybean lecithin, soybean lecithin, medium chain triglycerides, and liquid paraffins, and combinations thereof.
Examples of solvents include water (eg purified water), ethanol, propylene glycol, olive oil, sesame oil, castor oil, soybean oil, and liquid paraffin.
Examples of pH regulators or buffers are phosphoric acid, lactic acid, acetic acid, carbonic acid and salts thereof, hydrochloric acid, sodium hydroxide, potassium hydroxide, citrate buffer (0.2M), and sodium hydrogen carbonate, and they. Includes combinations of.
Examples of suspending agents include gum arabic, crystalline cellulose, bee gum, xanthan gum, guar gum, gelatin, metros and salts thereof, carmellose and salts thereof, and combinations thereof.
Examples of colorants include caramel, β-carotene, and various food dyes (eg, Food Yellow No. 1, Food Red No. 2), and combinations thereof.
Examples of stabilizers include silicone resins, glycerin, salts of edetic acids, salts of sodium chloride, and sodium metabisulfite, and combinations thereof.
Examples of defoamers include silicone resins, silicone oils, ethanol, glycerin fatty acid esters, dimethylpolysiloxane, sucrose fatty acid esters, polyoxyl stearyl acid, sosulfitan fatty acid esters, sorbitan trioleate, and polysorbate 80, and combinations thereof. Include.
Examples of solubilizers include propylene glycol, cyclodextrin, and arginine, and combinations thereof.
Examples of bitter masking agents include phosphatidyls [eg BMI-60 (product name, Kao)].
Examples of thickeners other than gellan gum include agar, xanthan gum, and guar gum and combinations thereof.
これらの添加成分の量は、その種類、及び目的等に応じて、適宜設定される。 The amount of these additive components is appropriately set according to the type, purpose, and the like.
経口ゲル状組成物のpH
本発明者らは、ビタミンB1類(例、フルスルチアミン又はその塩酸塩)を安定に含有し、尚且つゲル状形態を安定に保持する経口ゲル状組成物を提供するためには、該組成物のpHの上限を、好ましくは3.8以下、より好ましくは3.6以下、さらに好ましくは3.5以下とすることを見出した。また、該組成物のpHの下限を、好ましくは2.5以上、より好ましくは2.8以上、さらに好ましくは3.1以上、特に好ましくは3.3以上とすることを見出した。
即ち、本発明の経口ゲル状組成物におけるpHは、好ましくは2.5〜3.8の範囲内、より好ましくは2.5〜3.6の範囲内、さらに好ましくは2.8〜3.1の範囲内である。
PH of oral gel composition
In order to provide an oral gel-like composition that stably contains vitamin B 1 (eg, fursultiamine or a hydrochloride thereof) and stably retains a gel-like form, the present inventors have said that. It has been found that the upper limit of the pH of the composition is preferably 3.8 or less, more preferably 3.6 or less, still more preferably 3.5 or less. It has also been found that the lower limit of the pH of the composition is preferably 2.5 or more, more preferably 2.8 or more, still more preferably 3.1 or more, and particularly preferably 3.3 or more.
That is, the pH of the oral gel composition of the present invention is preferably in the range of 2.5 to 3.8, more preferably in the range of 2.5 to 3.6, and even more preferably in the range of 2.8 to 3. It is within the range of 1.
pHの調整は、例えば、上記したpH調節剤又は緩衝剤の使用により行えばよい。
本発明における経口ゲル状組成物のpHを測定するにあたっては、当該組成物を市販の食品用ミキサーを用いて微細化し、均質な溶液とした上で、日局・一般試験法に記載のpH測定法に従い、試験を実施すればよい。
The pH may be adjusted, for example, by using the above-mentioned pH adjuster or buffer.
In measuring the pH of the oral gel-like composition in the present invention, the composition is refined using a commercially available food mixer to prepare a homogeneous solution, and then the pH is measured according to the Japanese Pharmacopoeia / General Test Method. The test may be conducted in accordance with the law.
経口ゲル状組成物の形態
本発明の経口ゲル状組成物は、例えば、第十七改正日本薬局方の製剤総則に規定される経口液剤、すなわち『経口投与する、液状又は流動性のある粘稠なゲル状の製剤』として好適に用いることができる。
製剤が、ゲル等の固形製剤ではなく、液状又は流動性のある粘稠なゲル状の製剤であることは、技術常識に照らして判断される。
Form of Oral Gel-like Composition The oral gel-like composition of the present invention is, for example, an oral liquid preparation specified in the 17th revised Japanese Pharmacopoeia General Formulation Regulations, that is, "orally administered, liquid or fluid viscous". It can be suitably used as a “gel-like preparation”.
It is judged in light of common general knowledge that the preparation is not a solid preparation such as a gel, but a liquid or fluid viscous gel-like preparation.
ゲル状組成物の粘稠さは、ゲル状組成物の硬さによって示すことができ、硬さが大きいゲル状組成物は、粘稠性が高いということができる。
本発明の経口ゲル状組成物は、例えば、後記の試験方法によって測定される硬さが、好ましくは0.05N以上、より好ましくは0.08N以上、更に好ましくは0.10N以上である。このような硬さを有することにより、本発明の経口ゲル状組成物は、誤嚥を防止できるし、投与又は摂取も容易である。
本発明の経口ゲル状組成物は、当該硬さが、好ましくは0.50N以下、より好ましくは0.35N以下、更に好ましくは0.30N以下である。このような硬さを有することにより、本発明の経口ゲル状組成物は、投与又は摂取が容易である。
本発明の経口ゲル状組成物は、当該硬さが、好ましくは0.05〜0.50Nの範囲内、より好ましくは0.08〜0.35Nの範囲内、更に好ましくは0.10〜0.30Nの範囲内ある。
The consistency of the gel-like composition can be indicated by the hardness of the gel-like composition, and it can be said that the gel-like composition having a large hardness has a high viscosity.
The oral gel composition of the present invention has, for example, a hardness measured by the test method described later, preferably 0.05 N or more, more preferably 0.08 N or more, still more preferably 0.10 N or more. By having such hardness, the oral gel-like composition of the present invention can prevent aspiration and is easy to administer or ingest.
The oral gel composition of the present invention has a hardness of preferably 0.50 N or less, more preferably 0.35 N or less, still more preferably 0.30 N or less. By having such hardness, the oral gel-like composition of the present invention is easy to administer or ingest.
The oral gel-like composition of the present invention has a hardness preferably in the range of 0.05 to 0.50 N, more preferably in the range of 0.08 to 0.35 N, and further preferably in the range of 0.10 to 0. It is in the range of .30N.
本発明の経口ゲル状組成物は、経口投与、又は経口摂取される。
本発明の経口ゲル状組成物は、医薬品、医薬部外品、保健機能食品(例:機能性表示食品、栄養機能食品、特定保健用食品)、又は一般食品(例:栄養補助食品、健康補助食品、栄養調整食品)等として用いることができる。
The oral gelled composition of the present invention is orally administered or orally ingested.
The oral gel composition of the present invention is a pharmaceutical product, a non-pharmaceutical product, a food with health claims (eg, food with functional claims, food with nutritional function, food for specified health use), or a general food (eg, dietary supplement, health supplement). It can be used as food, nutritionally adjusted food), etc.
本発明の経口ゲル状組成物は、そのゲル状形態が高い安定性を有する。
本発明において、ゲル状形態が高い安定性を有することとは、物性的には、
(1)苛酷な条件下(例:高温、酸性及び/又は長期間)での保存後も、離水が抑制されていること、及び/又は
(2)苛酷な条件下(例:高温、酸性及び/又は長期間)での保存後も、その硬さの低下が抑制されていること、を意味する。
また、官能的には、ゲル状組成物の食感が維持されていることを意味する。
The oral gel-like composition of the present invention has a high stability in its gel-like form.
In the present invention, the fact that the gel-like form has high stability means that, in terms of physical properties,
(1) Suppression of water separation even after storage under harsh conditions (eg high temperature, acidity and / or long term) and / or (2) harsh conditions (eg high temperature, acidity and / or long term) / Or even after storage for a long period of time), it means that the decrease in hardness is suppressed.
Also, sensually, it means that the texture of the gel-like composition is maintained.
ここで、ゲル状組成物の離水量の測定、及び離水率の算出は、次の測定方法により、実施される。
<ゲル状組成物の離水の測定方法>
当該測定方法では、ふるいとして、目開き2mmのメッシュ[第十七改正日本薬局方、ふるい番号8.6号(2000μm)]、且つ直径200mmのふるいを使用する。
試験されるゲル状組成物を容器に入れて所定の保存条件に曝露した後、容器の内容物の全量を、ふるい下を敷いたふるい上に入れ、その質量を測定し、該質量をA(g)とする。次に、前記ふるいを45度傾けて1分間保持した後、当該ふるいから前記ふるい下に落ちた液体(離水)の質量を測定して、これをB(g)とし、次式により離水率を算出する。
離水率(%)=B(g)/A(g)×100
Here, the measurement of the amount of water separation and the calculation of the water separation rate of the gel-like composition are carried out by the following measurement methods.
<Measuring method of water separation of gel-like composition>
In the measuring method, a mesh having a mesh opening of 2 mm [17th revision Japanese Pharmacopoeia, sieve number 8.6 (2000 μm)] and a sieve having a diameter of 200 mm are used as a sieve.
After the gelled composition to be tested is placed in a container and exposed to predetermined storage conditions, the entire contents of the container are placed on a sieve under a sieve, the mass is measured, and the mass is A ( g). Next, after tilting the sieve by 45 degrees and holding it for 1 minute, the mass of the liquid (water separation) that fell from the sieve under the sieve was measured, and this was defined as B (g), and the water separation rate was calculated by the following equation. calculate.
Water separation rate (%) = B (g) / A (g) x 100
本発明の経口ゲル状組成物において、ゲル状形態の高い安定性は、苛酷な条件下(例:高温、酸性及び/又は長期間)の保存後においても、ゲル状組成物の適当な硬さが維持されている。 In the oral gel composition of the present invention, the high stability of the gel form is the appropriate hardness of the gel composition even after storage under harsh conditions (eg, high temperature, acidity and / or long term). Is maintained.
本発明の経口ゲル状組成物は、好ましくは、冷蔵庫内で(すなわち、約4℃で)8週間保存した場合の硬さに対する、50℃で同期間保存した場合の硬さの比(この定義から理解される通り、硬さの比は100%を超える場合がある。)が、好ましくは65%以上、より好ましくは70%以上、更に好ましくは80%以上である。 The oral gel composition of the present invention is preferably the ratio of hardness when stored in a refrigerator (ie, at about 4 ° C.) for 8 weeks to hardness when stored at 50 ° C. for the same period (this definition). As can be understood from the above, the hardness ratio may exceed 100%), but is preferably 65% or more, more preferably 70% or more, still more preferably 80% or more.
本発明の経口ゲル状組成物の硬さの測定については、前記ゲル状組成物の離水の測定方法で、ふるいに残ったゲル状組成物を試料として使用して、次の測定方法により、実施される。
<ゲル状組成物の硬さの試験方法>
当該試験には、材料試験機として、直線運動により物質の圧縮応力を測定することが可能な材料試験機 EZ-SX(製品名、島津製作所)(ロードセル:50N、試験治具:ユニバーサルデザインフード試験セット、ソフトウェア : TRAPEZIUM X テクスチャー、恒温装置 : 冷熱恒温器)、又はその同等品を使用する。
試料を容器(直径40mm、高さ20mm)に高さ15mmまで充填し、前記材料試験機を用いて、樹脂性の円形プランジャー(直径20mm、高さ8mm)により、圧縮速度10mm/秒、及びクリアランス5mmの条件で2回圧縮し、その時の圧縮応力を測定する。測定は、20±2℃で行う。
2回の圧縮における圧縮応力の最大値を、試料の硬さとする。
The hardness of the oral gel-like composition of the present invention is measured by the following measurement method using the gel-like composition remaining on the sieve as a sample in the method for measuring water separation of the gel-like composition. Will be done.
<Test method for hardness of gel-like composition>
For this test, as a material tester, the material tester EZ-SX (product name, Shimadzu Corporation) (load cell: 50N, test jig: universal design hood test) that can measure the compressive stress of a substance by linear motion. Set, software: TRAPEZIUM X texture, thermostat: cold thermostat), or equivalent.
The sample was filled in a container (diameter 40 mm, height 20 mm) up to a height of 15 mm, and using the material tester, a resin circular plunger (diameter 20 mm, height 8 mm) was used to compress the sample at a compression rate of 10 mm / sec. Compress twice under the condition of a clearance of 5 mm, and measure the compressive stress at that time. The measurement is performed at 20 ± 2 ° C.
The maximum value of compressive stress in two compressions is taken as the hardness of the sample.
当該試験における試料としては、前記ゲル状組成物の離水の測定方法で、ふるいに残ったゲル状組成物を使用して実施する。
従って、ふるいにゲル状組成物が残らない場合は、当該硬さを測定できないが、当業者が通常理解する通り、ふるいにゲル状組成物が残らない場合、その硬さは、ふるいに残ったゲル状組成物の硬さよりも低いことが合理的に推定される。
As a sample in the test, the gel-like composition remaining on the sieve is used in the method for measuring water separation of the gel-like composition.
Therefore, if the gel-like composition does not remain on the sieve, the hardness cannot be measured, but as those skilled in the art usually understand, if the gel-like composition does not remain on the sieve, the hardness remains on the sieve. It is reasonably estimated that the hardness is lower than that of the gel-like composition.
本発明において、ゲル状組成物の硬さの高い安定性は、苛酷な条件下(例:高温、酸性及び/又は長期間)での保存後も、当該組成物の食感が維持されている。
当該組成物の食感は、前記離水の抑制、及び前記硬さの維持と、密接に関連する。
In the present invention, the high hardness stability of the gel-like composition maintains the texture of the composition even after storage under harsh conditions (eg, high temperature, acidity and / or long term). ..
The texture of the composition is closely related to the suppression of water separation and the maintenance of the hardness.
経口ゲル状組成物の製造方法
本発明の経口ゲル状組成物は、公知の経口ゲル状組成物の製造方法を採用して製造すればよく、具体的には、例えば、
(1)前記ジェランガム及び水(例:精製水)を混合した後、加熱して、前記ジェランガムを溶解させる工程、
(2)前記ジェランガム及び水以外の成分を前記工程(1)で得られた液体と混合して液状組成物を得る工程、を含む製造方法により、製造できる。
前記ジェランガム及び水以外の成分は、適宜、前記工程(1)で得られた液体と混合する前に、予め混合されていてもよい。
Method for Producing Oral Gel-like Composition The oral gel-like composition of the present invention may be produced by adopting a known method for producing an oral gel-like composition. Specifically, for example,
(1) A step of mixing the gellan gum and water (eg, purified water) and then heating to dissolve the gellan gum.
(2) It can be produced by a production method including a step of mixing the components other than gellan gum and water with the liquid obtained in the step (1) to obtain a liquid composition.
The components other than gellan gum and water may be appropriately mixed in advance before being mixed with the liquid obtained in the step (1).
経口ゲル状組成物の包装
本発明の経口ゲル状組成物には、経口投与又は経口摂取されるゲル状組成物に通常採用される包装が施される。当該包装は、その形態に応じて、慣用の方法により実施すればよい。
特に、本発明の経口ゲル状組成物は、苛酷な条件下でも、ゲル状形態が高い安定性を有し、且つビタミンB1類を安定に含有できるので、包装工程の条件の制限も小さい。
従って、本発明の経口ゲル状組成物には容易且つ好適に様々な包装方法を採用できる。
Packaging of Oral Gel-like Composition The oral gel-like composition of the present invention is provided with the packaging usually used for a gel-like composition to be orally administered or orally ingested. The packaging may be carried out by a conventional method according to the form.
In particular, oral gel composition of the present invention, even under severe conditions, has a form of gel stability is high, and since the vitamin B 1 class can stably contains smaller restriction conditions of the packaging process.
Therefore, various packaging methods can be easily and preferably adopted for the oral gel-like composition of the present invention.
経口ゲル状組成物の包装は、例えば、前記経口ゲル状組成物の製造方法で得られた液状組成物を容器に充填することにより、実施できる。
このような包装の好適な例として、パウチタイプの容器による包装が挙げられる。
The packaging of the oral gel-like composition can be carried out, for example, by filling the container with the liquid composition obtained by the method for producing the oral gel-like composition.
A suitable example of such packaging is packaging in a pouch-type container.
前記パウチタイプの容器としては、汎用されているものを使用でき、例えば、アルミ箔、及び樹脂フィルム(例:ポリエチレンテレフタレート、ナイロン、及びポリエチレン、並びにこれらの組合せ)が積層されているフィルム素材から形成された容器を使用できる。
前記パウチタイプの容器は、レトルト殺菌可能な容器、すなわちレトルトパウチ容器である。
前記パウチタイプの容器は、スタンディング袋型、ガゼット袋型、又は三方袋型等の任意のタイプである。
前記パウチタイプの容器は、好適にスパウトを備えている。これによれば、簡便に、経口投与又は経口摂取できる。
1個のパウチタイプの容器に封入されている本発明の経口ゲル状組成物は、例えば、80mL〜300mLの範囲内である。
As the pouch-type container, a general-purpose container can be used, and is formed of, for example, a film material in which aluminum foil and a resin film (eg, polyethylene terephthalate, nylon, and polyethylene, and a combination thereof) are laminated. Can be used in the container.
The pouch-type container is a retort-sterilizable container, that is, a retort pouch container.
The pouch type container is of any type such as a standing bag type, a gusset bag type, or a three-sided bag type.
The pouch-type container preferably comprises a spout. According to this, it can be easily orally administered or orally ingested.
The oral gel composition of the present invention enclosed in one pouch-type container is, for example, in the range of 80 mL to 300 mL.
前記の説明から理解される通り、パウチタイプの容器に包装されている、本発明の経口ゲル状組成物もまた提供する。
特に、本発明の経口ゲル状組成物は、苛酷な条件下でも、ゲル状形態が高い安定性を有し、且つビタミンB1類を安定に含有できるので、包装工程の条件の制限も小さく、容易且つ好適にパウチタイプの容器に包装される。
As understood from the above description, the oral gel composition of the present invention, which is packaged in a pouch-type container, is also provided.
In particular, oral gel composition of the present invention, even under severe conditions, a form of gel has a high stability, and because vitamin B 1 class can stably contains smaller restriction conditions of the packaging process, Easily and preferably packaged in a pouch-type container.
これから理解される通り、本発明は、本発明の経口ゲル状組成物、及び当該経口ゲル状組成物を内封するパウチタイプの容器を備えるバック製剤(パウチ製剤、又はパウチ型製剤)もまた提供する。 As will be understood, the present invention also provides the oral gel-like composition of the present invention and a bag formulation (pouch formulation or pouch-type formulation) comprising a pouch-type container containing the oral gel-like composition. To do.
当該バック製剤は、好適には、液体を実質的に含有しない。
具体的には、当該パウチ製剤、パウチ型製剤、又はバック製剤においては、その内容物全体にする液体の量が、好ましくは10質量%以下、より好ましくは5質量%以下、更に好ましくは3質量%以下である。
The bag formulation preferably contains substantially no liquid.
Specifically, in the pouch preparation, the pouch type preparation, or the back preparation, the amount of the liquid to be added to the entire contents is preferably 10% by mass or less, more preferably 5% by mass or less, still more preferably 3% by mass. % Or less.
以下、実施例によって本発明をさらに詳細に説明するが、本発明はこれに限定されるものではない。実施例中、特に記載が無い限り、「%」は「w/w%」を意味する。 Hereinafter, the present invention will be described in more detail by way of examples, but the present invention is not limited thereto. In the examples, unless otherwise specified, "%" means "w / w%".
[実施例1]
以下の表1に示した材料を用いて、経口ゲル状組成物を調整した。
[Example 1]
The oral gel composition was prepared using the materials shown in Table 1 below.
[ゲル状組成物の調製方法]
(1)1袋当たりの量として、表1に記載のフルスルチアミン塩酸塩(表中、「TTFD」)から塩化マグネシウムまでの材料を精製水に溶解した。次いで、得られた水溶液のpHを、塩酸と水酸化ナトリムを適宜使用して、pH2.5、pH2.8、pH3.1、pH3.4、及びpH3.8のいずれかに調整した。その後、これらの水溶液を50℃まで加温した。
(2)一方、表中のジェランガム(脱アシル型(LA)ジェランガム、三栄源エフエフアイ)からブドウ糖までの材料を同一の袋に添加して混合し、この混合物を、攪拌しながら精製水に添加し、溶解した。この水溶液を、電子レンジで沸騰するまで加温した。
(3)上記(1)で得られた各水溶液と、上記(2)で得られた水溶液を混合し、精製水を加えて100mLにした。
(4)得られた溶液を口栓付きアルミパウチに充填し、pH2.5、2.8、3.1、3.4、及び3.8の各ゲル状組成物を得た。
[Method for preparing gel-like composition]
(1) As the amount per bag, the materials from fursultiamine hydrochloride (“TTFD” in the table) to magnesium chloride shown in Table 1 were dissolved in purified water. Then, the pH of the obtained aqueous solution was adjusted to one of pH 2.5, pH 2.8, pH 3.1, pH 3.4, and pH 3.8 by appropriately using hydrochloric acid and sodium hydroxide. Then, these aqueous solutions were heated to 50 ° C.
(2) On the other hand, the ingredients from gellan gum (deacyl type (LA) gellan gum, Saneigen FFI) to glucose in the table are added to the same bag and mixed, and this mixture is added to purified water with stirring. And dissolved. The aqueous solution was heated in a microwave until it boiled.
(3) Each aqueous solution obtained in (1) above was mixed with the aqueous solution obtained in (2) above, and purified water was added to make 100 mL.
(4) The obtained solution was filled in an aluminum pouch with a spout to obtain gel-like compositions having pH 2.5, 2.8, 3.1, 3.4, and 3.8.
[実施例2]
以下の材料を用いて、経口ゲル状組成物を調整した。
[材料]
・粘稠剤:
ジェランガム(脱アシル型(LA)ジェランガム、三栄源エフエフアイ)
寒天(カンテン末 PS−6 (製品名、伊那食品工業))
・フルスルチアミン塩酸塩(以下、TTFDともいう)
・クエン酸緩衝液 0.2M
[Example 2]
The oral gel composition was prepared using the following materials.
[material]
・ Viscous agent:
Gellan gum (deacyl type (LA) gellan gum, Saneigen FFI)
Agar (Kanten powder PS-6 (product name, Ina Food Industry))
-Fursultiamine hydrochloride (hereinafter also referred to as TTFD)
・ Citric acid buffer 0.2M
1袋当たりの量として、1.5mgのフルスルチアミン塩酸塩(TTFD)と、pH2.8、3.1、3.4、3.8の50mLのクエン酸緩衝液(0.2M)と、200mgのジェランガム(実施例2)または300mgの寒天(比較例1)を加熱および撹拌混合し、TTFDとジェランガムまたは寒天を溶解させ、精製水を加えて100mLにした。
得られた溶液を口栓付きアルミパウチに充填し、pH2.8、3.1、3.4、及び3.8の各ゲル状組成物を得た。
The amount per bag was 1.5 mg of fursultiamine hydrochloride (TTFD) and 50 mL of citrate buffer (0.2 M) having a pH of 2.8, 3.1, 3.4, and 3.8. 200 mg of gellan gum (Example 2) or 300 mg of agar (Comparative Example 1) was heated and mixed by stirring to dissolve TTFD and gellan gum or agar, and purified water was added to make 100 mL.
The obtained solution was filled in an aluminum pouch with a spout to obtain gel-like compositions having pH 2.8, 3.1, 3.4, and 3.8.
[試験例1]フルスルチアミン塩酸塩(TTFD)の安定性
実施例1として製造した、pH2.5、2.8、3.1、3.4、及び3.8の各ゲル状組成物を、それぞれ60℃で、2週間保存した。
60℃、2週間保存後のTTFD量を測定し、その残存率(製造直後の初期含量と比較した残存率)を算出した。当該残存率(%)を表2に示した。
[Test Example 1] Stability of Fursultiamine Hydrochloride (TTFD) Gel-like compositions having pH 2.5, 2.8, 3.1, 3.4, and 3.8 prepared as Example 1 were prepared. , Each stored at 60 ° C. for 2 weeks.
The amount of TTFD after storage at 60 ° C. for 2 weeks was measured, and the residual rate (residual rate compared with the initial content immediately after production) was calculated. The residual rate (%) is shown in Table 2.
表2の結果より、60℃で2週間の苛酷な条件での保存において、TTFD量はいずれのpHでも高い割合で残存した。 From the results in Table 2, the amount of TTFD remained at a high rate at any pH after storage at 60 ° C. for 2 weeks under harsh conditions.
[試験例2]ゲル状組成物の離水
各ゲル状組成物を、50℃および4℃(対照)で8週間保存後、後述する測定方法により、離水量を測定した後、離水率を算出し、これから[(50℃で8週間保存後の離水率)−(4℃で8週間保存後の離水率)]の差を算出した。
当該離水率の差を表3に示した。
[Test Example 2] Water separation of gel-like composition After storing each gel-like composition at 50 ° C. and 4 ° C. (control) for 8 weeks, the amount of water separation is measured by the measurement method described later, and then the water separation rate is calculated. From this, the difference of [(water separation rate after storage at 50 ° C. for 8 weeks)-(water separation rate after storage at 4 ° C. for 8 weeks)] was calculated.
The difference in the water separation rate is shown in Table 3.
<ゲル状組成物の離水の測定方法>
当該測定方法では、ふるいとして目開き2mmのメッシュ[第十七改正日本薬局方、ふるい番号8.6号(2000μm)]、且つ直径200mmのふるいを使用した。試験されるゲル状組成物を容器に入れて所定の保存条件に曝露した後、容器の内容物の全量を、ふるい下を敷いたふるい上に入れ、その質量を測定し、当該質量をA(g)とした。
前記ふるいを45度傾けて1分間保持した後、当該ふるいから前記ふるい下に落ちた液体(離水)の質量を測定し、これをB(g)とし、次式により離水率を算出した。
離水率(%)=B(g)/A(g)×100
<Measuring method of water separation of gel-like composition>
In the measuring method, a mesh having a mesh opening of 2 mm [17th revision Japanese Pharmacopoeia, sieve number 8.6 (2000 μm)] and a sieve having a diameter of 200 mm were used as a sieve. After the gelled composition to be tested is placed in a container and exposed to predetermined storage conditions, the entire contents of the container are placed on a sieve under a sieve, the mass is measured, and the mass is A ( g).
After tilting the sieve by 45 degrees and holding it for 1 minute, the mass of the liquid (water separation) that fell from the sieve under the sieve was measured, and this was defined as B (g), and the water separation rate was calculated by the following formula.
Water separation rate (%) = B (g) / A (g) x 100
表3の結果より、本発明のゲル状組成物では、いずれのpHでも離水が高度に抑制された。 From the results shown in Table 3, in the gel-like composition of the present invention, water separation was highly suppressed at any pH.
[試験例3]ゲル状組成物の硬さ
各ゲル状組成物の保存後[50℃又は4℃(対照)で8週間保存後]の硬さを以下の方法で測定し、その比(50℃/対照)を算出し、表4に示した。
[Test Example 3] Hardness of gel-like composition The hardness of each gel-like composition after storage [after storage at 50 ° C. or 4 ° C. (control) for 8 weeks] was measured by the following method, and the ratio (50) was measured. ° C./control) was calculated and shown in Table 4.
<ゲル状組成物の硬さの試験方法>
当該試験には、材料試験機として、直線運動により物質の圧縮応力を測定することが可能な材料試験機 EZ-SX(製品名、島津製作所)(ロードセル:50N、試験治具:ユニバーサルデザインフード試験セット、ソフトウェア : TRAPEZIUM X テクスチャー、恒温装置 : 冷熱恒温器)を使用した。
試料を容器(直径40mm、高さ20mm)に高さ15mmまで充填し、前記材料試験機を用いて、樹脂性の円形プランジャー(直径20mm、高さ8mm)により、圧縮速度10mm/秒、及びクリアランス5mmの条件で2回圧縮し、その時の圧縮応力を測定した。測定は、ゲルを20℃の恒温槽に入れ、20℃に安定させた後、20±2℃で行った。
2回の圧縮における圧縮応力の最大値を、試料の硬さとした。
<Test method for hardness of gel-like composition>
For this test, as a material tester, the material tester EZ-SX (product name, Shimadzu Corporation) (load cell: 50N, test jig: universal design hood test) that can measure the compressive stress of a substance by linear motion. Set, software: TRAPEZIUM X texture, thermostat: cold thermostat) was used.
The sample was filled in a container (diameter 40 mm, height 20 mm) up to a height of 15 mm, and using the material tester, a resin circular plunger (diameter 20 mm, height 8 mm) was used to compress the sample at a compression rate of 10 mm / sec. It was compressed twice under the condition of a clearance of 5 mm, and the compressive stress at that time was measured. The measurement was carried out at 20 ± 2 ° C. after placing the gel in a constant temperature bath at 20 ° C. and stabilizing it at 20 ° C.
The maximum value of the compressive stress in the two compressions was taken as the hardness of the sample.
ゲル状組成物について、保存後[50℃又は4℃(対照)で8週間保存後]の硬さを上記方法により測定し、その比(50℃で8週間保存後/対照)を算出した。
当該硬さの比を表4に示した。
表中、「ND」は、ふるい上にゲル状組成物が残らず、その硬さを測定できなかったことを表す。このことは、ゲル状組成物のゲル様の形態、特にその適度な硬さが全く、又はほとんど維持されなったことを示す。
For the gel-like composition, the hardness [after storage at 50 ° C. or 4 ° C. (control) for 8 weeks] was measured by the above method, and the ratio (after storage at 50 ° C. for 8 weeks / control) was calculated.
The hardness ratio is shown in Table 4.
In the table, "ND" indicates that no gel-like composition remained on the sieve and its hardness could not be measured. This indicates that the gel-like morphology of the gel-like composition, especially its moderate hardness, was maintained at all or almost no.
表4の結果より、本発明の経口ゲル状組成物では、50℃で8週間の苛酷な条件での保存において、いずれのpHにおいても、比較例のゲル状組成物に比べて、その適度な硬さが高度に維持された。 From the results shown in Table 4, the oral gel composition of the present invention was appropriately stored at 50 ° C. for 8 weeks under harsh conditions at any pH as compared with the gel composition of the comparative example. High hardness was maintained.
製剤例1
表5の処方に従い、ビタミンB1類(フルスルチアミン塩酸塩)、及び1.5g/Lのジェランガム(脱アシル型(LA)ジェランガム、三栄源エフエフアイ)を含有し、ビタミンB1類1質量部に対して、ジェランガムを100質量部含有する、経口ゲル状組成物(pHは3.1に調整)を調製した。
Formulation Example 1
According to the formulation of Table 5, vitamin B 1 class (fursultiamine hydrochloride), and 1.5 g / L gellan gum (deacylated (LA) gellan gum, San-Ei Gen Efuefu eye) containing vitamin B 1 class 1 mass An oral gel-like composition (pH adjusted to 3.1) containing 100 parts by mass of gellan gum was prepared.
本発明によれば、ビタミンB1類、及びジェランガムを含有し、且つビタミンB1類の1質量部に対して、ジェランガムを10〜2000質量部の範囲内で含有することなどによって、ビタミンB1類を安定に含有し、且つゲル状形態も安定な経口ゲル状組成物が提供される。 According to the present invention, vitamin B 1 and gellan gum are contained, and vitamin B 1 is contained in the range of 10 to 2000 parts by mass with respect to 1 part by mass of vitamin B 1. An oral gel-like composition that stably contains the above species and has a stable gel-like form is provided.
Claims (5)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019068455A JP2020164483A (en) | 2019-03-29 | 2019-03-29 | Oral gel-like composition |
JP2023132414A JP2023144045A (en) | 2019-03-29 | 2023-08-16 | Oral gel-like composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019068455A JP2020164483A (en) | 2019-03-29 | 2019-03-29 | Oral gel-like composition |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2023132414A Division JP2023144045A (en) | 2019-03-29 | 2023-08-16 | Oral gel-like composition |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2020164483A true JP2020164483A (en) | 2020-10-08 |
Family
ID=72717275
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019068455A Pending JP2020164483A (en) | 2019-03-29 | 2019-03-29 | Oral gel-like composition |
JP2023132414A Pending JP2023144045A (en) | 2019-03-29 | 2023-08-16 | Oral gel-like composition |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2023132414A Pending JP2023144045A (en) | 2019-03-29 | 2023-08-16 | Oral gel-like composition |
Country Status (1)
Country | Link |
---|---|
JP (2) | JP2020164483A (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002119225A (en) * | 2000-10-17 | 2002-04-23 | Morinaga & Co Ltd | Gel-like food and method for modifying food feeling of the gel-like food |
JP2010195761A (en) * | 2009-01-30 | 2010-09-09 | House Foods Corp | Composition for sleepiness prevention |
JP2011250716A (en) * | 2010-05-31 | 2011-12-15 | Sanei Gen Ffi Inc | Vitamin b1 composition with improved flavor, and method of suppressing flavor of vitamin b1 |
CN103070239A (en) * | 2011-10-25 | 2013-05-01 | 北京康比特体育科技股份有限公司 | Dairy product used for alleviating exercise-induced fatigue, and preparation method thereof |
JP2013150556A (en) * | 2012-01-24 | 2013-08-08 | Morinaga & Co Ltd | Jelly beverage and method for producing the same |
WO2015062518A1 (en) * | 2013-10-30 | 2015-05-07 | 帝斯曼知识产权资产管理有限公司 | Gel particles containing nutritive substance and preparation method and use thereof |
JP2016002060A (en) * | 2014-06-19 | 2016-01-12 | 日油株式会社 | Gelatinous nutritive composition |
-
2019
- 2019-03-29 JP JP2019068455A patent/JP2020164483A/en active Pending
-
2023
- 2023-08-16 JP JP2023132414A patent/JP2023144045A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002119225A (en) * | 2000-10-17 | 2002-04-23 | Morinaga & Co Ltd | Gel-like food and method for modifying food feeling of the gel-like food |
JP2010195761A (en) * | 2009-01-30 | 2010-09-09 | House Foods Corp | Composition for sleepiness prevention |
JP2011250716A (en) * | 2010-05-31 | 2011-12-15 | Sanei Gen Ffi Inc | Vitamin b1 composition with improved flavor, and method of suppressing flavor of vitamin b1 |
CN103070239A (en) * | 2011-10-25 | 2013-05-01 | 北京康比特体育科技股份有限公司 | Dairy product used for alleviating exercise-induced fatigue, and preparation method thereof |
JP2013150556A (en) * | 2012-01-24 | 2013-08-08 | Morinaga & Co Ltd | Jelly beverage and method for producing the same |
WO2015062518A1 (en) * | 2013-10-30 | 2015-05-07 | 帝斯曼知识产权资产管理有限公司 | Gel particles containing nutritive substance and preparation method and use thereof |
JP2016002060A (en) * | 2014-06-19 | 2016-01-12 | 日油株式会社 | Gelatinous nutritive composition |
Non-Patent Citations (2)
Title |
---|
AMAZON アリナミン メディカルバランス 販売頁, JPN6023003249, 24 January 2023 (2023-01-24), ISSN: 0005057964 * |
月刊フードケミカル, vol. 27(3), JPN6023017980, 2011, pages 54 - 56, ISSN: 0005057965 * |
Also Published As
Publication number | Publication date |
---|---|
JP2023144045A (en) | 2023-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5147239B2 (en) | Coenzyme Q10-containing emulsion composition | |
EA006141B1 (en) | Preparation of vitamin emulsions and concentrates thereof | |
EP0625312B1 (en) | Feeding composition | |
BR112012000115B1 (en) | composition comprising bioactive amino acids and / or peptides and marine oil in a stable oil-in-water emulsion, process for production and its uses | |
US10064835B2 (en) | Combination of beta-hydroxy-beta-methylbutyrate, arginine and glutamine for use in treating diabetic ulcers | |
JP5902815B2 (en) | Acid liquid nutrient | |
JP2021045135A (en) | Oral delivery product | |
JP6093343B2 (en) | Liquid for internal use | |
BR102017000315A2 (en) | JELLY | |
JPH06327435A (en) | Nutrition-supplying composition | |
JP7489071B2 (en) | Oral gel composition | |
JP2020164483A (en) | Oral gel-like composition | |
JP2002300854A (en) | Gelatinous composition and method for producing the same | |
ES2372467T3 (en) | IMMUNONUTRITIONAL COMPOSITION. | |
JP5611672B2 (en) | Oral jelly | |
JP5491943B2 (en) | Oral jelly containing vitamin B1 | |
JP6633896B2 (en) | Biotin-containing solution | |
JP7052997B2 (en) | Stabilizers, beverages and their manufacturing methods | |
EP4349344A1 (en) | Composition for improving or preventing iron deficiency anaemia | |
JP7201142B2 (en) | Folic acid-containing acidic composition with excellent stability of folic acid | |
JP7116043B2 (en) | High calorie nutritional composition and package | |
US9662304B1 (en) | Substituted glutaurine compounds and substituted glutaurine derivatives | |
EP2977047A1 (en) | Nutrition composition | |
JP2024052654A (en) | Soft capsule | |
JP2023046996A (en) | Composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220311 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20221020 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20221228 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230131 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230324 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20230516 |